
SINOVIAL HL PREFILLED SYRINGE 2ML
Indication: Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy related to joint alterations
Free delivery for orders over 89€*.
* in metropolitan France and excluding drugs
COXARTHRUM is indicated to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid of the arthritic joint.
COXARTHRUM exerts its therapeutic effect by viscosupplementation, a process by which the physiological and rheological properties of the synovial fluid of the arthritic hip are improved.
COXARTHRUM is indicated for the symptomatic treatment of coxarthrosis by intra-articular injection. COXARTHRUM must be administered only intra-articularly under radio-guidance or by ultrasound and this by a specialist doctor, to relieve the pain associated with osteoarthritis of the hip.
COXARTHRUM is a sterile, pyrogen-free and physiological viscoelastic solution of non-reticulated hyaluronic acid of non-animal origin.
This solution is presented in pre-filled, single-use syringes.
Each box contains a syringe of COXARTHRUM, a leaflet and a set of labels to ensure traceability.
STERILIZATION
COXARTHRUM syringes are sterilized by moist heat.
COXARTHRUM is indicated to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid of the arthritic joint.
COXARTHRUM exerts its therapeutic effect by viscosupplementation, a process by which the physiological and rheological properties of the synovial fluid of the arthritic hip are improved.
COXARTHRUM is indicated for the symptomatic treatment of coxarthrosis by intra-articular injection. COXARTHRUM should be administered only intra-articularly under radio-guidance or by ultrasound and this by a specialist physician, to relieve the pain associated with osteoarthritis of the hip.
COXARTHRUM should not be used in
- Patients with hypersensitivity to hyaluronic acid.
- Patients with autoimmune diseases, sarcoidosis, multiple severe allergies, cardiovascular diseases with anticoagulants.
- Patients under immunosuppressants, under interferon.
- Pregnant or breastfeeding women.
- Children.
COXARTHRUM should not be used in case of inflammatory pathology of the joint (RHUMATOID POLYARTHRITIS). COXARTHRUM must not be injected at the same time as an injectable corticoid.
COXARTHRUM is indicated only for intra-articular injections.
Do not inject intravascularly.
Do not inject outside the joint cavity or into the synovial tissue or capsule.
INCOMPATIBILITIES
Hyaluronic acid solution (sodium hyaluronate) is incompatible with quaternary ammonium salts such as Benzalkonium chloride. COXARTHRUM should never be placed in contact with this type of product or with surgical equipment that has been cleaned with this type of product.
ADVERSE REACTIONS
The practitioner must inform the patient of the potential immediate or delayed adverse effects related to the injection of this device before the procedure.
The different potential adverse effects are :
- Immediate side effects related to the injection: pain, redness, swelling at the injection site.
- Side effects of inflammatory origin: pseudo gouty attack. Chondrocalcinosis. Pseudo septic arthritis.
- Other side effects
Low efficiency or low effect of the treatment in relation to a very advanced stage of osteoarthritis of the hip.
The appearance and/or persistence of side effects must be reported by the patient to the practitioner as soon as possible, who will have to remedy them with an appropriate treatment.
Any other undesirable side effects related to the injection of the device should be reported to the distributor and/or the manufacturer.
COXARTHRUM is intended for intra-articular injection by a licensed specialist practitioner in accordance with applicable local regulations. The skill of the practitioner is essential to the success of the treatment, this device should be used by practitioners specifically trained in injection techniques.
The device must be used in its original packaging as supplied.
Any modification or use of this product outside the conditions of use defined in this leaflet that may affect its sterility, efficacy and tolerance will not be guaranteed.
The patient should be informed by the practitioner of the indications, contraindications, incompatibilities and potential adverse effects of the device before undertaking any treatment.
Procedure for use:
- Prior to injection, a rigorous prior disinfection of the area to be treated will be performed.
- Check the integrity of the sterility protector.
- Take the syringe and remove the protective tip.
- Hold the syringe barrel and insert the needle into the Luer-Lock system.
- Gently turn the needle clockwise to secure the needle in the LuerLock system.
- A visual check of the needle attachment will be performed.
- Remove the needle cap.
- Inject slowly.
Failure to follow these instructions may result in the needle coming off and/or the device leaking at the Luer Lock.
The dosing regimen for COXARTHRUM is one intra-articular injection.
WARNINGS
- Check the expiration date on the label.
- Do not reuse, sterility cannot be guaranteed
- Do not re-sterilize
- Used syringes should be disposed of in appropriate containers and refer to the current guidelines for disposal.
Sodium hyaluronate (fb) 75 mg
Sodium chloride 27 mg
Borate buffer Ph 7.2 qsp qsp 3 ml
(Sodium borate, Boric acid, PPI water)
STORAGE CONDITIONS
- Store between +2°C and 30°C.
- Protect from light and freezing
Indication: Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy related to joint alterations
Description : This medication is recommended for painful osteoarthritis of the knee, with effusion.
Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Symptomatic treatment ofosteoarthritis.
Arthrum H viscoelastic devices are recommended to maintain the endo-articular space, reduce pain and restore joint mobility by replacing and supplementing the elastoviscosity of the pathological synovial fluid in osteoarthritic joints.
OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in the case of tendon disorders.
Arthrum HCS 40mg/2ml is indicated for all types of painful synovial joint arthritis, particularly gonarthrosis.
Arthrum HCS is biologically similar to human synovial fluid and participates in the following functions: Protect the cartilage, Protect the synovial membrane, Reduce pain and improve mobility
Flect'Expert Patch Harpagophytum unties, softens and relieves immediately the joint and muscle tensions of everyday life by providing a warm effect.
Indicated in the symptomatic treatment of osteoarthritis.
Description : GCA2700 Gel combines 16 targeted active ingredients, including Harpagophytum extract, Helichrysum floral water and Gaultheria essential oil with a soothing and relaxing fragrance.
Indications: STRUCTUM is used in adults (over 15 years of age) for the treatment of pain and functional discomfort in osteoarthritis of the knee and hip. This drug has a slow onset of action, delayed by about 2 months, and its effect may persist after treatment has been stopped.
Sinovial® is indicated in cases of pain or reduced mobility in order to restore the physiological and rheological properties of arthritic joints.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Indication : Medicine indicated in the symptomatic treatment of osteoarthritis in particular of the hip and the knee. Chondrosulf contains chondroitin sulphate and is indicated for adults (over 15 years).
Indications: Synvisc-One (a viscosupplement) is a simple intra-articular injection used to relieve pain and discomfort associated with osteoarthritis of the knee for up to six months.